FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4037911000001103: Metyrapone 250mg capsules 100 capsule (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21905701000001119 Metyrapone 250mg capsules 100 capsule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21905801000001111 Metyrapone 250mg capsules 100 capsule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Metyrapone 250mg capsules 100 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Metyrapone 250mg capsules 100 capsule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Metyrapone 250mg capsules 100 capsule Is pack of Product containing precisely metyrapone 250 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Metyrapone 250mg capsules 100 capsule Has active ingredient Metyrapone false Inferred relationship Existential restriction modifier
Metyrapone 250mg capsules 100 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Metyrapone 250mg capsules 100 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Metyrapone 250mg capsules 100 capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Metyrapone 250mg capsules 100 capsule Has VMP Product containing precisely metyrapone 250 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Metyrapone 250mg capsules 100 capsule Has specific active ingredient Metyrapone true Inferred relationship Existential restriction modifier
Metyrapone 250mg capsules 100 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) 100 capsule Is a True Metyrapone 250mg capsules 100 capsule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start